Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialJoseph P Broderick, James Grotta, Jordan J Elm et al.|The Lancet|2026Cited by 5